Association of NOS3 tag polymorphisms with hypoxicischemic encephalopathy

Croatian Medical Journal

Volumn 52, Issue 3, 2011, Pages 396-402

  Šamija, Radenka Kuzmanić ^a   Primorac, Dragan ^b,c,d,e   Rešić, Biserka ^a   Lozić, Bernarda ^a   Krželj, Vjekoslav ^a   Tomasović, Maja ^a   Stoini, Eugenio ^f   Šamanović, Ljubo ^b   Benzon, Benjamin ^b   Pehlić, Marina ^b   Boraska, Vesna ^b   Zemunik, Tatijana ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

^c JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF NEW HAVEN   (United States)

^f Sibenik General Hospital   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HOSPITAL ADMISSION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PERINATAL ASPHYXIA; PREMATURITY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TERM BIRTH;

ALGORITHMS; APGAR SCORE; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STATISTICS AS TOPIC;

EID: 80051918584     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2011.52.396     Document Type: Article

References (34)

1. Volpe JJ. Hypoxic-ischemic encephalopathy. In: Volpe JJ, editor. Neurology of the newborn. Philadelphia (PA): WB Saunders; 2008. p.400-82.
2. Perlman JM. Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics. 2006;117:S28-33.
3. Lai MC, Yang SN. Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol. 2011;2011:609813.
4. Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium. 2004;36:265-75.
5. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298:249-58.
6. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199:8-17.
7. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997;20:132-9.
8. Endres M, Laufs U, Liao JK, Moskowitz MA. Targeting eNOS for stroke protection. Trends Neurosci. 2004;27:283-9.
9. Jones LC, Hingorani AD. Genetic regulation of endothelial function. Heart. 2005;91:1275-7.
10. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006;164:921-35.
11. Howard TD, Giles WH, Xu J, Wozniak MA, Malarcher AM, Lange LA, et al. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke. 2005;36:1848-51.
12. Baier RJ. Genetics of perinatal brain injury in the preterm infant. Front Biosci. 2006;11:1371-87.
13. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696-705.
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217-23.
15. International HapMap Consortium. The International HapMap Project. Nature. 2005;2003;426:789-96.
16. Nelson KB, Dambrosia JM, Iovannisci DM, Cheng S, Grether JK, Lammer E. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res. 2005;57:494-9.
17. Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Dambrosia JM, Munroe DJ, et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol. 2007;109:384-91.
18. Gauderman WJ. Sample size requirements for matched casecontrol studies of gene-environment interaction. Stat Med. 2002;21:35-50.
19. McKnight AJ, Patterson CC, Sandholm N, Kilner J, Buckham TA, Parkkonen M, et al. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a metaanalysis. Am J Nephrol. 2010;32:476-81.
20. Grontved A, Andersen LB, Franks PW, Verhage B, Wareham NJ, Ekelund U, et al. NOS3 variants, physical activity, and blood pressure in the European Youth Heart Study. Am J Hypertens. 2011;24:444-50.
21. Cho M, Hyun KS, Chung DC, Choi IY, Kim MJ, Chang JP. eNOS gene polymorphisms in perinatal hypoxic-ischemic encephalopathy. Korean Journal of Pathology. 2009;43:306-11.
22. Vannemreddy P, Notarianni C, Yanamandra K, Napper D, Bocchini J. Is an endothelial nitric oxide synthase gene mutation a risk factor in the origin of intraventricular hemorrhage? Neurosurg Focus. 2010;28:E11.
23. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17:3147-53.
24. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190-3.
25. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002;20:2023-7.
26. Presciuttini S, Curcio M, Chillemi R, Barbuti S, Scatena F, Carli G, et al. Promoter polymorphisms of the NOS3 gene are associated with hypnotizability-dependent vascular response to nociceptive stimulation. Neurosci Lett. 2009;467:252-5.
27. Dani C, Bertini G. Inhaled nitric oxide for the treatment of preterm infants with respiratory distress syndrome. Neonatology. 2008;94:87-95.
28. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006;355:354-64.
29. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353:23-32.
30. Olivier P, Loron G, Fontaine RH, Pansiot J, Dalous J, Thi HP, et al. Nitric oxide plays a key role in myelination in the developing brain. J Neuropathol Exp Neurol. 2010;69:828-37.
31. Marks JD, Schreiber MD. Inhaled nitric oxide and neuroprotection in preterm infants. Clin Perinatol. 2008;35:793-807.
32. Gibson CS, Maclennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics. 2008;122:1079-85.
33. Miller SP, Wu YW, Lee J, Lammer EJ, Iovannisci DM, Glidden DV, et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke. 2006;37:2678-83.
34. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36:388-93.